- No mas: Principal bans Spanish language in intercom announcement
- Hacking software could put ‘zombie drone army’ in user’s hands
- Support for stricter gun laws drops: poll
- 10 whales dead, 41 others stranded in Everglades
- John Boehner faces bipartisan pressure to allow gay-rights vote
- Martin Bashir resigns from MSNBC over ‘ill-judged’ comments about Sarah Palin
- Rep. Duncan Hunter: While Obama prays for Iranian change, U.S. should ready its nukes
- Best company ever? Veteran Beer Co. exists to employ vets, provide quality beer
- Iran official: Sanctions ‘utterly failed’ to stop nuclear program
- ‘Black Santa’ display at IU sparks student outrage
Independent voices from the The Washington Times Communities
Topic - Seth Morgan
Back in your great-grandfather's day, streetcars cranked their way around Greater Washington with fairly predictable regularity. In the early 20th century, family weekends might include "riding the lines" out to amusement parks in Glen Echo, Bethesda or far Northeast, lines locals used daily to get to work, school or shopping.
Federal health regulators have approved the first pill to treat the underlying causes of multiple sclerosis, a debilitating nervous system disorder that has traditionally been treated with injectable drugs.
"Transportation is economics," said Seth Morgan, associate planner with Pace Suburban Bus in Chicago. "It helps focus the location of development in regions that are already growing. But it's not a magic wand."
"People say you get used to the side effects _ the discomfort and burning around the injection site _ but the fact of the matter is I never did," said Morgan, who worked as a neurologist before being diagnosed with the disease.